Design of a Biobrick<Sup>TM</Sup> Compatible Gene Expression

Total Page:16

File Type:pdf, Size:1020Kb

Design of a Biobrick<Sup>TM</Sup> Compatible Gene Expression Utah State University DigitalCommons@USU All Graduate Theses and Dissertations Graduate Studies 5-2011 Design of a BioBrickTM Compatible Gene Expression System for Rhodobacter sphaeroides Junling Huo Utah State University Follow this and additional works at: https://digitalcommons.usu.edu/etd Part of the Biology Commons Recommended Citation Huo, Junling, "Design of a BioBrickTM Compatible Gene Expression System for Rhodobacter sphaeroides" (2011). All Graduate Theses and Dissertations. 877. https://digitalcommons.usu.edu/etd/877 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@USU. It has been accepted for inclusion in All Graduate Theses and Dissertations by an authorized administrator of DigitalCommons@USU. For more information, please contact [email protected]. DESIGN OF A BIOBRICKTM COMPATIBLE GENE EXPRESSION SYSTEM FOR RHODOBACTER SPHAEROIDES by Junling Huo A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in Biological Engineering Approved: Professor H. Scott Hinton Dr. Daryll B DeWald Major Professor Committee Member Dr. Charles Miller Dr. Ronald C. Sims Committee Member Committee Member Dr. Jon Y Takemoto Dr. Byron R. Burnham Committee Member Dean of Graduate Studies UTAH STATE UNIVERSITY Logan, Utah 2011 ii Copyright © Junling Huo 2011 All Rights Reserved iii ABSTRACT Design of a BioBrickTM Compatible Gene Expression System for Rhodobacter sphaeroides by Junling Huo, Doctor of Philosophy Utah State University, 2011 Major Professor: Professor H. Scott Hinton Department: Biological Engineering The concept of introducing engineering principles of abstraction and standardization into synthetic biology has received increasing attention in the past several years and continues to be in the forefront of synthetic biology. One direction being pursued by synthetic biologists is creation of modular biological parts (BioBrickTM) that can be readily synthesized and mixed together in different combinations. However, most standard BioBrickTM parts in the Registry were designed for E. coli, although synthesis of specific BioBrickTM parts for other bacteria, such as for yeast and cyanobacteria, have begun. Besides, at the present time, there are only three chassis, which include E. coli, Bacillus subtilis, and a cell-free chassis, available in the Registry. Thus, the choices of BioBrickTM chassis are very limited. In addition, most BioBrickTM parts in the Registry have not been characterized. In the present study, the BioBrickTM concept was extended to the photosynthetic bacteria, Rhodobacter sphaeroides. In order to do that, a BioBrickTM compatible gene iv expression system was designed to convert R. sphaeroides to potential solar powered bio-factories or bio-refineries. This gene expression system was composed of BioBrickTM promoters, Ribosome Binding Sites (RBSs), and terminators in a BioBrickTM compatible cloning vector and its function has been validated through the expression of fluorescent proteins. In addition, a bioluminescence-based BioBrickTM characterization method was developed in this study. This method was based on a cloning vector that includes two adjacent operons, with each expressing a different luciferase reporter gene. The measured optical signals from the two expressed bioluminescent reporters were then used to predict the performance of promoters, RBSs, and terminators. Based on this bioluminescence-based BioBrickTM characterization method, two BioBrickTM characterizations kits, one for E. coli and one for R. sphaeroides, were developed. BioBrickTM parts that include seven promoters, six RBSs, and six terminators were characterized using the E. coli characterization kit. R. sphaeroides BioBrickTM parts were characterized when R. sphaeroides containing the BioBrickTM measurement constructs were cultured by both anaerobic photosynthesis and by aerobic respiration respectively. The experimental results showed that the activities of these R. sphaeroides BioBrickTM parts were very similar for the cells growing under two different conditions. (182 pages) v ACKNOWLEDGMENTS I am deeply grateful and indebted to my major advisor, Professor H. Scott Hinton, and Dr. Ronald C. Sims, for their consistent guidance, support, and encouragement during my graduate studies at Utah State University. Without their help and patience, this work would not have been possible to reach its final stage. In addition to introducing me to the subject of synthetic biology, the most important skill that I have learned from them was how to be an effective researcher and a good mentor. I would like to thank all my committee members, Dr. Daryll B DeWald, Dr. Charles Miller, and Dr. Jon Y Takemoto, for their guidance, criticisms, and insightful comments on my dissertation. I would like to convey my appreciation to Dr. Michelle Grilley (Dr. Takemoto‘s lab) and Dr. Sitaram Harihar (Dr. DeWald‘s Lab) for their technical help on my lab design. I would like to thank Ninglin Yin and Sarah Bastian from USU Center for Integrated Biosystems for their hard work on DNA sequencing support. I am extremely grateful to all members of SBC. I owe special thanks to Dr. Dong Chen and Dr. Jixun Zhan for their technical support and suggestions. I would like to thank all of my lab colleagues, Jason Brown, Mathew Kurian, Sanjib Shrestha, for useful discussion and cooperation. I would like to thank Melanie Ivans (executive assistant to the Dean), Jaclyn Evans (former staff assistant at SBC), Shelly Wardell (staff assistant at SBC), and Anne Martin (recruiter in Biological Engineering) for their assistance and enthusiasm during my research. vi I would also like to thank my good friends Gary Chiu, Frankie Chiu, and Kuanchiang Chen for their support in my daily life during this research. This work is supported by the USTAR synthetic Bio-manufacturing center (SBC). This support is gratefully acknowledged. Special thanks go to Dr. Samuel Kaplan and Dr. Jesus M. Eraso from University of Texas-Houston Medical School for providing technical support, Rhodobacter sphaeroides 2.4.1, E. coli S17-1, E coli DH5αPhe, and E. coli HB101/pRK2013; Dr. Masayuki Inui from Molecular Microbiology and Biotechnology group, Kyoto, Japan, for kindly providing cloning vectors pMG170/pMG171; Dr. Judith P. Armitage from Oxford center for integrative systems biology, University of Oxford, United Kingdom; and Elaine Byles (Dr. Armitage‘s lab), and Dr. Steven Porter from School of Biosciences, University of Exeter, United Kingdom for kindly providing cloning vectors pIND4 and technical discussions including the use of lactose inducible promoter in R. sphaeroides. Finally, I would like to express my deepest appreciation to my wife, Dr. Qin Li, my sons, Andy and Randy, my parents-in-law, and my sisters for their endless love, support, and encouragement. Junling Huo vii CONTENTS Page ABSTRACT……………………...…….…………………..………………….iii ACKNOWLEDGMENTS…………………………………..……………….…v LIST OF TABLES………………………...…..…..…………………………..xi LIST OF FIGURES.………………...………..…………………………….…xii CHAPTER 1 INTRODUCTION AND LITERATURE REVIEW……………....…1 1.1 Background……………………………………….......….…..1 1.1.1 Synthetic Biology……………………………….....…1 1.1.2 Standardization of Biological Parts: BioBrickTM….....2 1.2 Current status of BioBrickTM research.....................................7 1.2.1 BioBrickTM parts characterization ...............................7 1.2.2 BioBrickTM chassis.......................................................8 1.3 Rhodobacter sphaeroides……………………………….....…9 1.3.1 Cloning vectors for R. sphaeroides.…..….................11 1.3.2 Restriction endonucleases in R. sphaeroides……….15 1.3.3 Operonic structure of R. sphaeroides…...………......16 1.4 Motivation and Research objective………………………....19 1.5 Outline of the Dissertation…………………………........….19 References………………………………………....….………….....21 2 DESIGN OF A BIOBRICKTM COMPATIBLE GENE EXPRESSION SYSTEM FOR RHODOBACTER SPHAEROIDES …………...…...27 2.1 Background………………………………….…………...…28 2.1.1 Cloning vectors for R. sphaeroides….….....………..30 2.1.2 Promoters for R. sphaeroides……........………….…31 2.1.3 RBSs for R. sphaeroides…........................................32 viii 2.1.4 Terminators for R. sphaeroides……..…....…………32 2.2 Results……………………………………….………...……33 2.2.1 BioBrickTM vectors for R. sphaeroides………...…...33 2.2.2 BioBrickTM promoters for R. sphaeroides…….....….34 2.2.3 BioBrickTM RBS for R. sphaeroides…...…….……..35 2.2.4 BioBrickTM terminator for R. sphaeroides……....….38 2.2.5 Expression of cyan fluorescent protein (CFP) in R. sphaeroides.................................................................40 2.2.6 Gene expression system tested with fluorescent proteins.......................................................................41 2.3 Discussion and conclusion.......…………….……………….42 2.4 Methods……...………………….…………..………………43 2.4.1 Bacterial strains and plasmids...….………………....43 2.4.2 Culture conditions…….......……….………………..43 2.4.3 DNA techniques…………………........………….…44 References……………...………………………..……….…………47 3 A NEW BIOLUMINESCNECE -BASED METHOD FOR CHARACTERIZING BIOBRICKTM PROMOTERS, RIBOSOME BINDING SITES, AND TERMINATORS.......................................51 3.1 Background………….……………….…………………......52 3.2 Results.......................………………….…...……………….55 3.2.1 Definition and model of BioBrickTM activity.............55 3.2.2 Principle of promoter measurement....................…...56 3.2.3 Principle of RBS measurement..................................60 3.2.4 Principle
Recommended publications
  • Gene Composer: Database Software for Protein Construct Design, Codon
    BMC Biotechnology BioMed Central Software Open Access Gene Composer: database software for protein construct design, codon engineering, and gene synthesis Don Lorimer1,2,3, Amy Raymond1,2,JohnWalchli3,4,MarkMixon3,4, Adrienne Barrow1,3, Ellen Wallace1,3,RenaGrice1,3,AlexBurgin1 and Lance Stewart*1,2,3 Address: 1deCODE biostructures, Inc 7869 NE Day Road West, Bainbridge Island, WA, 98110, USA, 2Seattle Structural Genomics Center for Infectious Disease, Bainbridge Island, WA, 98110, USA, 3Accelerated Technologies Center for Gene to 3D Structure, Bainbridge Island, WA, 98110, USA and 4Emerald BioSystems, Inc 7869 NE Day Road West, Bainbridge Island, WA, 98110, USA E-mail: Don Lorimer - [email protected]; Amy Raymond - [email protected]; John Walchli - [email protected]; Mark Mixon - [email protected]; Adrienne Barrow - [email protected]; Ellen Wallace - [email protected]; Rena Grice - [email protected]; Alex Burgin - [email protected]; Lance Stewart* - [email protected] *Corresponding author Published: 21 April 2009 Received: 16 October 2008 BMC Biotechnology 2009, 9:36 doi: 10.1186/1472-6750-9-36 Accepted: 21 April 2009 This article is available from: http://www.biomedcentral.com/1472-6750/9/36 © 2009 Lorimer et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: To improve efficiency in high throughput protein structure determination, we have developed a database software package, Gene Composer, which facilitates the information-rich design of protein constructs and their codon engineered synthetic gene sequences.
    [Show full text]
  • Paulo Miguel Da Silva Gaspar Optimizaç˜Ao De Genes Para
    Departamento de Universidade de Aveiro Electr´onica,Telecomunica¸c~oese Inform´atica, 2010 Paulo Miguel Optimiza¸c~aode genes para express~aoheter´ologa da Silva Gaspar Gene optimization for heterologous expression Departamento de Universidade de Aveiro Electr´onica,Telecomunica¸c~oese Inform´atica, 2010 Paulo Miguel Optimiza¸c~aode genes para express~aoheter´ologa da Silva Gaspar Gene optimization for heterologous expression Tese apresentada `aUniversidade de Aveiro para cumprimento dos requisitos necess´ariospara a obten¸c~aodo grau de Mestre em Engenharia de Computa- dores e Telem´atica,realizada sobre a orienta¸c~aoci^entificado Dr. Jos´eLu´ıs Oliveira (Professor Associado da Universidade de Aveiro e investigador no IEETA) e da Dr.a Gabriela Moura (Professora Auxiliar na Universidade de Aveiro e investigadora no CESAM). o j´uri/ the jury presidente / president Joaquim Arnaldo Carvalho Martins Professor Catedr´aticoda Universidade de Aveiro vogais / examiners committee Jos´eLu´ısOliveira Professor Associado da Universidade de Aveiro (orientador) Gabriela Moura Professora Auxiliar na Universidade de Aveiro (co-orientadora) Rui Pedro Lopes Professor Coordenador do departamento de Inform´aticae Comunica¸c~oes do Instituto Polit´ecnicode Bragan¸ca agradecimentos / Elaborar uma tese sobre um assunto algo complexo em cerca de cem p´aginas acknowledgements ´ede facto uma tarefa dif´ıcil. Compreender em alguns meros par´agrafoso reconhecimento e a gratifica¸c~aopor quem me apoiou, ´eirrealiz´avel. Agrade¸co em primeiro lugar ao meu professor e orientador Jos´eLu´ısOliveira, que me acompanhou, guiou e ajudou durante todo o progresso desta inves- tiga¸c~ao,mostrando-se sempre presente e dispon´ıvel, e cujos conselhos e apoio foram vitais.
    [Show full text]
  • Attenuated Viruses Useful for Vaccines Für Impfstoffe Geeignete Abgeschwächte Viren Virus Attenues Utiles Pour Des Vaccins
    (19) TZZ _¥__T (11) EP 2 139 515 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: A61K 39/13 (2006.01) 13.06.2018 Bulletin 2018/24 (86) International application number: (21) Application number: 08799746.6 PCT/US2008/058952 (22) Date of filing: 31.03.2008 (87) International publication number: WO 2008/121992 (09.10.2008 Gazette 2008/41) (54) ATTENUATED VIRUSES USEFUL FOR VACCINES FÜR IMPFSTOFFE GEEIGNETE ABGESCHWÄCHTE VIREN VIRUS ATTENUES UTILES POUR DES VACCINS (84) Designated Contracting States: (74) Representative: Pohlman, Sandra M. et al AT BE BG CH CY CZ DE DK EE ES FI FR GB GR df-mp Dörries Frank-Molnia & Pohlman HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT Patentanwälte Rechtsanwälte PartG mbB RO SE SI SK TR Theatinerstrasse 16 Designated Extension States: 80333 München (DE) AL BA MK RS (56) References cited: (30) Priority: 30.03.2007 US 909389 P WO-A2-02/095363 US-A1- 2004 209 241 07.03.2008 US 68666 US-A9- 2004 097 439 US-B1- 6 696 289 (43) Date of publication of application: • BURNS CARA CARTHEL ET AL: "Modulation of 06.01.2010 Bulletin 2010/01 poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in (73) Proprietor: The Research Foundation of the State thecapsid region", JOURNAL OF VIROLOGY, vol. University of 80, no. 7, April 2006 (2006-04), pages 3259-3272, New York XP002633525, -& WO 2006/042156 A2 (US GOV Albany, NY 12207 (US) HEALTH & HUMAN SERV [US]; KEW OLEN M [US]; BURNS CARA C [US]; S) 20 April 2006 (72) Inventors: (2006-04-20) • WIMMER, Eckard • MUELLER STEFFEN ET AL: "Reduction of the East Setauket, NY 11733 (US) rate of poliovirus protein synthesis through • SKIENA, Steve large-scale codon deoptimization causes Setauket, NY 11733 (US) attenuation of viral virulence by lowering specific • MUELLER, Steffen infectivity.", JOURNAL OF VIROLOGY, vol.
    [Show full text]
  • Methylase-Assisted Subcloning for High Throughput Biobrick Assembly
    Methylase-assisted subcloning for high throughput BioBrick assembly Ichiro Matsumura Emory University School of Medicine, Department of Biochemistry, Atlanta, GA, United States of America ABSTRACT The BioBrick standard makes possible iterated pairwise assembly of cloned parts with- out any depletion of unique restriction sites. Every part that conforms to the standard is compatible with every other part, thereby fostering a worldwide user community. The assembly methods, however, are labor intensive or inefficient compared to some newer ones so the standard may be falling out of favor. An easier way to assemble BioBricks is described herein. Plasmids encoding BioBrick parts are purified from Escherichia coli cells that express a foreign site-specific DNA methyltransferase, so that each is subsequently protected in vitro from the activity of a particular restriction endonuclease. Each plasmid is double-digested and all resulting restriction fragments are ligated together without gel purification. The ligation products are subsequently double-digested with another pair of restriction endonucleases so only the desired insert-recipient vector construct retains the capacity to transform E. coli. This 4R/2M BioBrick assembly protocol is more efficient and accurate than established workflows including 3A assembly. It is also much easier than gel purification to miniaturize, automate and perform more assembly reactions in parallel. As such, it should streamline DNA assembly for the existing community of BioBrick users, and possibly encourage others to join. Subjects Bioengineering, Molecular Biology, Synthetic Biology Keywords BioBrick assembly, Methylase-assisted cloning, Synthetic biology, Laboratory automation, DNA methyltransferase Submitted 27 April 2020 Accepted 10 August 2020 Published 11 September 2020 INTRODUCTION Corresponding author A bottleneck in many synthetic biology projects is the physical linkage of cloned synthetic Ichiro Matsumura, [email protected] genes (``parts'') to each other to form longer functional assemblies (``devices'').
    [Show full text]
  • A New Biobrick Assembly Strategy Designed for Facile Protein Engineering
    A New Biobrick Assembly Strategy Designed for Facile Protein Engineering Ira E. Phillips∗ and Pamela A. Silver∗ April 18, 2006 Abstract The existing biobrick assembly technique[1] provides a straightforward way to combine standardized biological components, termed biobricks. This system, however, is limited in that each protein-encoding biobrick must contain a complete translated region. Signal sequences or other pro- tein domains often convey a specific function to the protein to which they are attached; hence, each domain should be considered an independent biological part. With the current assembly technique, assembling such parts is not possible. This paper presents a revised assembly strategy that is compatible with the current biobrick definition and permits the construction of fusion proteins. Introduction The standard biobrick assembly technique was created in an attempt to simplify the construction of long concatemeric pieces of DNA often used in synthetic biology [1]. Previously existing techniques were limiting in that one often needed to design a unique cloning strategy for each desired construct. Moreover, the intermediates in the cloning of one construct would be of little value in creating other constructs. As a solution to these problems, T. Knight developed a novel cloning strategy that permits standardization of biological parts or biobricks [1]. Each biobrick can be placed in front of or behind another biobrick using a standard protocol that is independent of the content of the parts involved. (To insert a biobrick in front of another, simply digest the upstream biobrick with EcoRI and SpeI. Cut out this insert and ligate into a vector containing the second part cut with EcoRI and XbaI.
    [Show full text]
  • A Biobrick Compatible Strategy for Genetic Modification of Plants Boyle Et Al
    A BioBrick compatible strategy for genetic modification of plants Boyle et al. Boyle et al. Journal of Biological Engineering 2012, 6:8 http://www.jbioleng.org/content/6/1/8 Boyle et al. Journal of Biological Engineering 2012, 6:8 http://www.jbioleng.org/content/6/1/8 METHODOLOGY Open Access A BioBrick compatible strategy for genetic modification of plants Patrick M Boyle1†, Devin R Burrill1†, Mara C Inniss1†, Christina M Agapakis1,7†, Aaron Deardon2, Jonathan G DeWerd2, Michael A Gedeon2, Jacqueline Y Quinn2, Morgan L Paull2, Anugraha M Raman2, Mark R Theilmann2, Lu Wang2, Julia C Winn2, Oliver Medvedik3, Kurt Schellenberg4, Karmella A Haynes1,8, Alain Viel3, Tamara J Brenner3, George M Church5,6, Jagesh V Shah1* and Pamela A Silver1,5* Abstract Background: Plant biotechnology can be leveraged to produce food, fuel, medicine, and materials. Standardized methods advocated by the synthetic biology community can accelerate the plant design cycle, ultimately making plant engineering more widely accessible to bioengineers who can contribute diverse creative input to the design process. Results: This paper presents work done largely by undergraduate students participating in the 2010 International Genetically Engineered Machines (iGEM) competition. Described here is a framework for engineering the model plant Arabidopsis thaliana with standardized, BioBrick compatible vectors and parts available through the Registry of Standard Biological Parts (www.partsregistry.org). This system was used to engineer a proof-of-concept plant that exogenously expresses the taste-inverting protein miraculin. Conclusions: Our work is intended to encourage future iGEM teams and other synthetic biologists to use plants as a genetic chassis.
    [Show full text]
  • Computational Tools for Synthetic Gene Optimization
    Computational Tools for Synthetic Gene Optimization Numaan Cheema - Computer Science, 21 Mentor: Dr. Dimitris Papamichail Introduction ● Last two decades have seen a rise of computational tools developed by software developers and biologists for synthetic biology ● Many types: ○ Optimizing constructs for manufacturability ○ Enabling design of genetic circuits ○ Redesign of protein-coding genes for expression ● My focus: To examine gene optimization computation tools and to analyze their efficacy in performing synthetic gene optimization Gene Editing Genome editing (also called gene editing) is a group of technologies that give scientists the ability to change an organism's DNA. These technologies allow genetic material to be added, removed, or altered at particular locations in the genome Figure 2. Top down view of why gene optimization (part of synthetic biology) is important. (Microbial Electrochemical and Fuel Cells, 2016) How does redesign work with tools? 1. The first step is to retrieve the natural DNA sequence of letters across a chromosome 2. Choose an appropriate tool that performs the wanted optimization features Examples of these include: a. Everytime it sees the letter series TAG change it to TAA b. Delete a class of genes referred to as tRNA genes from their positions c. Shuffle the DNA sequence according the researchers desired order d. Insert or Delete portions of DNA to enhance or minimize particular genes 3. Once the alterations and optimization is completed, then researchers can purchase DNA chunks from companies that can be easily manipulated in a lab Common Optimization Objectives 1. Codon Usage Bias optimization Altering rare codons in the target gene so they more closely reflect the codon usage of host without modifying the amino acid sequence 2.
    [Show full text]
  • Before Peer Production: Infrastructure Gaps and the Architecture of Openness in Synthetic Biology
    BEFORE PEER PRODUCTION: INFRASTRUCTURE GAPS AND THE ARCHITECTURE OF OPENNESS IN SYNTHETIC BIOLOGY David Singh Grewal* In memoriam Mark Fischer (1950 – 2015)µ * Professor of Law, Yale Law School, and Director, BioBricks Foundation. The views expressed here are my own, and do not reflect the views of any of the organizations or entities with which I am or have been affiliated. Among those to whom I owe thanks, I am especially grateful to Drew Endy, President of the BioBricks Foundation (BBF) who worked to educate me about synthetic biology, and later invited me to join the board of directors of the BBF, and to the late Mark Fischer, who was the lead drafter (along with Drew Endy, Lee Crews, and myself) of the BioBrick™ Public Agreement, and to whose memory this Article is dedicated. I am also grateful to other past and present directors and staff of the BBF, including Richard Johnson, Linda Kahl, Tom Knight, Thane Krier, Nathalie Kuldell, Holly Million, Jack Newman, Randy Rettberg, and Pamela Silver. I have benefitted from conversations about synthetic biology and open source theory with a number of other scientists, including Rob Carlson, George Church, Jason Kelly, Manu Prakash, Zach Serber, Reshma Shetty, Christina Smolke, Ron Weiss and with a number of lawyers, scholars, and open source advocates including Yochai Benkler, James Boyle, Daniela Cammack, Paul Cammack, Paul Goldstein, Hank Greely, Janet Hope, Margot Kaminski, Mark Lemley, Stephen Maurer, Eben Moglen, Lisa Ouellette, Jedediah Purdy, Arti Rai, Pamela Samuelson, Jason Schultz, and Andrew Torrance, and especially Talli Somekh, who first introduced me to synthetic biology and noted the connections between my work in network theory and new developments in biotechnology.
    [Show full text]
  • Computational Tools and Algorithms for Designing Customized
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE REVIEW ARTICLE published: 06provided October by 2014 Frontiers - Publisher Connector BIOENGINEERING AND BIOTECHNOLOGY doi: 10.3389/fbioe.2014.00041 Computational tools and algorithms for designing customized synthetic genes Nathan Gould 1, Oliver Hendy 2 and Dimitris Papamichail 1* 1 Department of Computer Science, The College of New Jersey, Ewing, NJ, USA 2 Department of Biology, The College of New Jersey, Ewing, NJ, USA Edited by: Advances in DNA synthesis have enabled the construction of artificial genes, gene cir- Ilias Tagkopoulos, University of cuits, and genomes of bacterial scale. Freedom in de novo design of synthetic constructs California, Davis, USA provides significant power in studying the impact of mutations in sequence features, and Reviewed by: verifying hypotheses on the functional information that is encoded in nucleic and amino Yinjie Tang, Washington University, USA acids. To aid this goal, a large number of software tools of variable sophistication have M. Kalim Akhtar, University College been implemented, enabling the design of synthetic genes for sequence optimization London, UK based on rationally defined properties. The first generation of tools dealt predominantly *Correspondence: with singular objectives such as codon usage optimization and unique restriction site incor- Dimitris Papamichail, Department of Computer Science, The College of poration. Recent years have seen the emergence of sequence design tools that aim to New Jersey, 2000 Pennington Road, evolve sequences toward combinations of objectives.The design of optimal protein-coding Ewing, NJ 08628, USA sequences adhering to multiple objectives is computationally hard, and most tools rely on e-mail: [email protected] heuristics to sample the vast sequence design space.
    [Show full text]
  • DNA Assembly & Synthetic Biology
    Now includes NEBExpress® Cell-free E. coli Protein Synthesis System DNA Assembly & Synthetic Biology TOOLS TO SUPPORT DESIGN AND DNA ASSEMBLY 1 0 01 0 1 SYNTHETIC BIOLOGY DNA Assembly & Synthetic Biology – Tools to support your design and assembly The goal of synthetic biology, in which genes and proteins are viewed as parts or devices, is redesigning and/or assembling them in novel ways to create a new and useful functionality. These projects often rely on the ordered assembly of multiple DNA sequences to create large, artificial DNA structures, and methods have evolved to simplify this process. New England Biolabs now offers several products that can be used for DNA assembly and cloning. Use this chart to determine which product would work best to assemble your DNA. NEBuilder HiFi Gibson NEB Golden Gate USER® Enzyme DNA Assembly Assembly® Assembly Kit (NEB #M5505) (BsaI-HF®v2, (NEB #E2621) (NEB #E5510) BsmBI-v2) Thermolabile (NEB #E5520) (NEB #E2611) USER II Enzyme (NEB #E2623) (NEB #E1601) (NEB #E1602) (NEB #M5508) PROPERTIES Removes 5´ or 3´ End Mismatches *** * N/A N/A Assembles with High Fidelity at Junctions *** ** *** *** Tolerates Repetitive Sequences at Ends * * *** *** Generates Fully Ligated Product *** *** *** NR Joins dsDNA with Single-stranded Oligo *** ** NR NR Assembles with High Efficiency with Low Amounts of DNA *** ** ** ** Accommodates Flexible Overlap Lengths *** *** * ** APPLICATIONS Simple Cloning (1-2 Fragments) *** *** *** *** 4-6 Fragment Assembly (one pot) *** *** *** *** 7-11 Fragment Assembly (one pot) ***
    [Show full text]
  • Synthetic Biology for Biotechnology- Regulatory Decision Makers from the Americas Th Th (San Jose, 16 and 17 March 2016)
    15/03/2016 Proceedings of the First Seminar on Synthetic Biology for Biotechnology- Regulatory Decision Makers from the Americas th th (San Jose, 16 and 17 March 2016) Inter-American Institute for Cooperation on Agriculture (IICA) Technical Editor: Pedro J. Rocha Salavarrieta Organized por: IICA and U.S. Department of Agriculture (USDA) Financed by: USDA & IICA Inter-American Institute for Cooperation on Agriculture (IICA), 2017 Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas by IICA is published under license from Creative Commons Attribution-ShareAlike 3.0 IGO (CC-BY-SA 3.0 IGO) (http://creativecommons.org/licenses/by-sa/3.0/igo/) Based on a work at www.iica.int IICA encourages fair use of this document. Proper citation is requested. Inter-American Institute for Cooperation on Agriculture (IICA, CR), 2017. Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas (San Jose, 16th and 17th March 2016). Technical Editor: P. J. Rocha. San José, CR, IICA. Disclaimer: The content of this publication is responsibility of its authors and does not reflect IICA´s official position. This publication is also available in electronic (PDF) format from Institute’s Web site: http://www.iica.int. Editorial coordination: Pedro J. Rocha Mechanical editing: Pedro J. Rocha Text translation: IICA Layout: Pedro J. Rocha Cover design: Pedro J. Rocha Proceedings of the First Seminar on Synthetic Biology for Biotechnology-Regulatory Decision Makers from the Americas (2016: San Jose, Costa Rica) / Inter-American Institute for Cooperation on Agriculture, United States Department of Agriculture.
    [Show full text]
  • Synthetic Biology: Scope, Applications and Implications
    Cover and back spread:Cover and back spread 29/4/09 14:42 Page 2 Synthetic Biology: scope, applications and implications Synthetic biology josi q7v2:Synthetic biology 29/4/09 14:41 Page 1 Synthetic Biology: scope, applications and implications © The Royal Academy of Engineering ISBN: 1-903496-44-6 May 2009 Published by The Royal Academy of Engineering 3 Carlton House Terrace London SW1Y 5DG Copies of this report are available online at www.raeng.org.uk/synbio Tel: 020 7766 0600 Fax: 020 7930 1549 www.raeng.org.uk Registered Charity Number: 293074 Synthetic biology josi q7v2:Synthetic biology 29/4/09 14:41 Page 2 Contents Executive summary Recommendation 1 Recommendation 2 Recommendation 3 Chapter 1– An Introduction 1.1: What is synthetic biology? 1.1.1: Biological systems 1.1.2: Systems approach 1.2: Relevant aspects of biological systems 1.2.1: Living systems 1.2.2: Self-organisation 1.2.3: Noise 1.2.4: Feedback and cell signalling 1.2.5: Biological complexity 1.3: The emergence of synthetic biology 1.3.1: Why now? 1.3.2: Developments in ICT 1.3.3: Developments in biology 1.3.4: The relationship between systems biology and synthetic biology 1.3.5: The Engineering design cycle and rational design in synthetic biology 1.3.6: Bioparts 1.3.7: Potential areas of application 1.3.8: Parallels in synthetic chemistry 1.3.9 ‘Bottom-up’ approaches in synthetic biology Chapter 2 – Fundamental 2.1: Technological enablers techniques in synthetic biology 2.1.1: Computational modelling 2.1.2: DNA sequencing 2.1.3: DNA synthesis 2.1.4: Yields 2.1.5: Future trends in modern synthesis 2.1.6: Large scale DNA oligonucleotide synthesis 2.1.7: Potential for innovation and microfluidics 2.1.
    [Show full text]